logo.png
Precede Biosciences Presents Data on Liquid Biopsy Comprehensive Epigenomic Profiling of MS Patients at ECTRIMS 2024
19 sept. 2024 10h50 HE | Precede Biosciences, Inc.
Precede Biosciences Presents Data on Liquid Biopsy Comprehensive Epigenomic Profiling of MS Patients at ECTRIMS 2024
Angitia Biopharmaceuticals to Present Data on AGA2118 for Osteoporosis at ASBMR 2024
16 sept. 2024 07h30 HE | Angitia Biopharmaceuticals
Angitia announces multiple presentations at ASBMR.
MetasTx-Logo_HoRes.jpg
MetasTx Welcomes Esteemed Cancer Scientist Dr. Jonathan Chernoff to the Board of Managers
13 sept. 2024 07h13 HE | MetasTx LLC
Dr. Chernoff’s decision to join the Board of Managers reflects his strong belief in MetasTx’s science and strategic direction.
MetasTx-Logo_HoRes.jpg
Harvey Homan to Highlight MetasTx’s Game-Changing Approach to Cancer Treatment at PA Life Science Futures
12 sept. 2024 06h58 HE | MetasTx LLC
MetasTx aims to revolutionize cancer treatment by targeting p21-activated kinase (PAK-1), a critical driver of metastasis in solid tumors.
Drug Discovery Informatics Market
Drug Discovery Informatics Strategic Business Report 2024: Market to Reach $4.8 Billion by 2030 - Advances in Cloud-Based and SaaS Informatics Platforms Propel Growth in Collaborative Drug Development
09 sept. 2024 10h36 HE | Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Drug Discovery Informatics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Drug...
MDA Kickstart
MDA Kickstart Program Launches for Ultra-Rare Neuromuscular Disease Drug Development
09 sept. 2024 09h00 HE | Muscular Dystrophy Association
New York, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today a new research program called MDA Kickstart for Ultra-Rare Neuromuscular Disease. The MDA...
Biognosys_Logo_Color.png
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
29 août 2024 08h27 HE | Biognosys AG
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
VMR Logo.png
Real World Evidence Solutions Market Surges to USD 3.17 Billion by 2031, Propelled by 13.92 % CAGR - Verified Market Research®
26 août 2024 10h15 HE | Verified Market Research
Lewes, Delaware, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The Global Real World Evidence Solutions Market Size is projected to grow at a CAGR of 13.92% from 2024 to 2031, according to a new report...
FullLogo_Transparent_NoBuffer.png
Project Mosaic Launches to Bring “Biopsies” to ALS Drug Development
21 août 2024 13h10 HE | Project Mosaic
Project Mosaic is proud to announce the launch of a groundbreaking initiative aimed at revolutionizing ALS drug development.
Indian Single-use Bioprocessing Probes And Sensors Market
India Single-use Bioprocessing Probes and Sensors Market Trends Analysis Report 2024-2030: Streamlined Operations and Cost-Effectiveness Drive Single-Use Technology Adoption
20 août 2024 10h16 HE | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "India Single-use Bioprocessing Probes And Sensors Market Size, Share & Trends Analysis Report By Type (pH Sensors, Oxygen Sensors), By Workflow...